A

Agile Therapeutics Inc
F:0AL

Watchlist Manager
Agile Therapeutics Inc
F:0AL
Watchlist
Price: 1.11 EUR -1.77% Market Closed
Market Cap: 9.3m EUR

Intrinsic Value

0AL price has not been updated for more than 7 months. This may indicate that the stock has been delisted.
0AL doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of 0AL.

The Intrinsic Value is calculated as the average of DCF and Relative values:

0AL Intrinsic Value
Not Available
Base Case Scenario
Compare 0AL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 0AL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Agile Therapeutics Inc

Current Assets 12m
Cash & Short-Term Investments 2.6m
Receivables 4.8m
Other Current Assets 4.6m
Non-Current Assets 623k
PP&E 385k
Other Non-Current Assets 238k
Current Liabilities 21.4m
Accounts Payable 12.6m
Accrued Liabilities 8.8m
Non-Current Liabilities 1.5m
Other Non-Current Liabilities 1.5m
Efficiency

Free Cash Flow Analysis
Agile Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Agile Therapeutics Inc

Revenue
21.5m USD
Cost of Revenue
-8.6m USD
Gross Profit
12.8m USD
Operating Expenses
-28.8m USD
Operating Income
-15.9m USD
Other Expenses
8.1m USD
Net Income
-7.8m USD
Fundamental Scores

0AL Profitability Score
Profitability Due Diligence

Agile Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Exceptional ROE
ROIC is Increasing
hidden
Profitability
Score

Agile Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

0AL Solvency Score
Solvency Due Diligence

Agile Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Agile Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0AL Price Targets Summary
Agile Therapeutics Inc

There are no price targets for 0AL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 0AL is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y